Introduction
============

Electrocyclizations of acyclic conjugated π-motifs are powerful tools to access five-, six- and seven-membered carbocycles;[@cit1] prominent examples include Nazarov cyclizations of pentadienyl cations[@cit2] and 6π electrocyclizations of trienes,[@cit3] which have found widespread applications in organic synthesis.

In the context of seven-carbon π-motifs, heptatrienyl anions **I** undergo facile 8π electrocyclizations *via* rapid interconversions among various anion configurations ([Scheme 1](#sch1){ref-type="fig"}).[@cit4] In contrast, heptatrienyl cations **III**[@cit5] exclusively undergo Nazarov reactions because of the difficulties of forming all σ-*cis* configured cations **V** that have a high energy state.[@cit5b] 1-Aza- and 1-oxaheptatrienyl cations[@cit6] were also reported to follow Nazarov cyclizations. The realization of a 6π electrocyclization of conjugated seven-membered cations is formidable but challenging. This work reveals the first success of such seven-membered cyclizations of gold-stabilized 3-azaheptatrienyl cations **V′** to form azacyclic products **3--4***via* a new C--C bond formation.![](c8sc00232k-u1.jpg){#ugr1}

![Electrocyclizations of conjugated π-motifs.](c8sc00232k-s1){#sch1}

The advent of gold catalysis has inspired new annulations between alkynes and poor nucleophiles.[@cit7] N--O containing nucleophiles serve as useful building blocks to construct valuable azacyclic frameworks.[@cit7] Ye and Hashmi reported interesting \[3+2\]-annulations of isoxazoles or benzisoxazoles with electron-rich ynamides, yielding substituted pyrrole derivatives through aza-Nazarov cyclizations of the key intermediate \[eqn (1)\].[@cit7],[@cit8] These \[3+2\]-annulations were extensively expanded to other N--O heterocycles including benzisoxazoles, 1,2,4-oxadiazoles, 1,4,2-dioxazoles and 4,5-dihydro-1,2,4-oxadiazoles, yielding additional five-membered azacycles as depicted in \[eqn (1)\].[@cit9] Here, we report two distinct \[4+3\]- and \[4+2\]-annulations between 3-en-1-ynamides and isoxazoles using varied catalysts. An Au([i]{.smallcaps}) catalyst alone delivers 4*H*-azepines **3--4** through 6π electrocyclizations of intermediates **V′** \[eqn (2)\] whereas a combined action of Au([i]{.smallcaps})/Zn([ii]{.smallcaps}) on the same reactants furnishes highly functionalized pyridines **5** \[eqn (3)\]. With our convenient synthesis, the synthetic utility of new 4*H*-azepines **3--4** is also reported.[@cit10]

Results and discussion
======================

We examined the reactions of 3-methyl-3-en-1-ynamide **1a** with 3,5-dimethylisoxazole **2a** using various gold catalysts. Heating this mixture (**1a**/**2a** = 1 : 2 ratio) in hot DCE with 5 mol% LAuCl/AgNTf~2~ \[L = *p*(*t*-Bu)~2~(*o*-biphenyl) and IPr\] afforded a \[4+3\]-annulation product, 4*H*-azepine **3a**, in 64% and 75% yields respectively ([Table 1](#tab1){ref-type="table"}, entries 1--2). Under these conditions, a low loading (1.2 equiv.) of 3,5-dimethylisoxazole **2a** gave **3a** in a decreased yield, *ca.* 62% (entry 3). With a 10 mol% catalyst, IPrAuCl/AgNTf~2~ gave a clean reaction, yielding desired **3a** up to 91% (entry 4). We tested other phosphine ligands such as PPh~3~ and P(OPh)~3~, yielding desired **3a** in satisfactory yields (78--81%, entries 5--6). Other counter anions such as OTf^--^ and SbF~6~^--^ were also effective in producing **3a** in 85--88% yields (entries 7--8). AgNTf~2~ alone was not active at all (entry 9).

###### \[4+3\]-Annulations over various gold catalysts

  ![](c8sc00232k-u2.jpg){#ugr2}                                                                                       
  ----------------------------------------- -------------------------------------- ------- ------- --------- -------- ----------------
  1[^*c*^](#tab1fnc){ref-type="table-fn"}   LAuCl/AgNTf~2~ \[5\]                   2       3       20        64       ---
  2[^*d*^](#tab1fnd){ref-type="table-fn"}   IPrAuCl/AgNTf~2~ \[5\]                 2       7       12        75       7 \[2.5 : 1\]
  3                                         IPrAuCl/AgNTf~2~ \[5\]                 1.2     7       23        62       5 \[1 : 1\]
  **4**                                     **IPrAuCl/AgNTf** ~**2**~ **\[10\]**   **2**   **3**   **---**   **91**   **Trace**
  5                                         PPh~3~AuCl/AgNTf~2~ \[10\]             2       3.5     ---       81       5 \[1.25 : 1\]
  6                                         \[PhO\]~3~PAuCl/AgNTf~2~ \[10\]        2       3.5     ---       78       13 \[1.1 : 1\]
  7                                         IPrAuCl/AgSbF~6~ \[10\]                2       2.5     ---       85       6 \[1.4 : 1\]
  8                                         IPrAuCl/AgOTf \[10\]                   2       2       ---       88       Trace
  9                                         AgNTf~2~ \[10\]                        2       15      33        ---      11

^*a*^\[**1a**\] = 0.15 M.

^*b*^Product yields are reported after separation from a silica column.

^*c*^L = *p*(*t*-Bu)~2~(*o*-biphenyl).

^*d*^IPr = 1,3-bis(diisopropylphenyl)-imidazol-2-ylidene. Ms = methanesulfonyl, DCE = 1,2-dichloroethane, and Tf = trifluoromethanesulfonyl.

Suitable substituents of 3-en-1-ynamides **1** are crucial to achieve 6π cyclizations of 3-azaheptatrienyl cations **V′** \[eqn (2)\]. We tested the reactions on 3-en-1-ynes **1b--1m** bearing a C(3)-substituent to circumvent aza-Nazarov cyclizations as reported in Ye\'s work.[@cit7] Herein, only entries 9 and 10 showed the presence of 3-azanorcaradienes **3′**. We examined these \[4+3\]-annulations on 3-methyl-3-en-1-ynamides **1b--1e** bearing various sulfonamides NTsR^4^ (R^4^ = Me, cyclopropyl, benzyl and N(*n*-C~4~H~9~)(--SO~2~Bu)), affording the desired 4*H*-azepines **3b--3e** in high yields (84--90%, [Table 2](#tab2){ref-type="table"}, entries 1--4). Nevertheless, this new annulation becomes less efficient for 3-en-1-ynamide **1f** bearing an oxazolidin-2-one to yield product **3f** in 64% yield (entry 5).

###### \[4+3\]-Annulations with various 3-en-1-ynamides

  ![](c8sc00232k-u3.jpg){#ugr3}
  -------------------------------
  ![](c8sc00232k-u4.jpg){#ugr4}

^*a*^\[**1**\] = 0.15 M.

^*b*^Product yields are reported after separation from a silica column. EWG = electron withdrawing group.

We altered the C(3)-substituents as in substrates **1g--1i**; their resulting products **3g--3h** (R^1^ = isopropyl and cyclopropyl) were obtained in 74--79%, and **3i** (R^1^ = Ph) with only 58% yield (entries 6--8). Notably, when a long *n*-butyl group was present as in species **1j** and **1k**, their corresponding reactions afforded compounds **3j**/**3j′** = 5/1 and **3k**/**3k′** = 11.1 : 1, respectively, in 55% and 68% yields (entries 9--10). For *E*-configured trisubstituted 3-en-1-yne **1l** (R^1^ = Me, R^2^ = Ph and R^3^ = H), 4*H*-azepine **3l** and pyrrole **6l** were obtained in equal proportions (entry 11). When a cyclohexenyl group was present for alkene as in species **1m**, pyrrole product **6m** was dominant over azepine **3m** (entry 12). Accordingly, preferable 3-en-1-ynes comprise a small R^2^ or R^3^ substituent whereas R^1^ must be substituted. Herein, the structures of 4*H*-azepines **3b** and **3l**, and pyrrole species **6m** were confirmed with X-ray diffraction.[@cit11]

Isoxazoles of a wide scope are compatible with these \[4+3\]-annulations, as depicted in [Table 3](#tab3){ref-type="table"}. The reaction of unsubstituted isoxazole **2b** with model 3-en-1-ynamide **1b** afforded the desired 4*H*-azepine **4a** in 84% yield, together with pyrrole **7a′** in only 8% yield (entry 1). Mono-substituted 3-methyl or 5-methyl isoxazoles **2c** and **2d** are also suitable for these annulations to afford compounds **4b** and **4c** in 75% and 87% yields, respectively (entries 2--3). We prepared additional 3,5-disubstituted isoxazoles **2e--2i** with R^1^ = alkyl and phenyl, and R^2^ = alkyl; their annulations proceed smoothly to produce desired **4d--4h** in 69--85% yields (entries 4--8). For di-substituted isoxazoles **2j** and **2k** bearing R^2^ = Ph, 4*H*-azepines **4i** and **4j** were obtained in 61% and 71% yields respectively, together with their rearrangement products **5i** and **5j** in 15--30% yields (entries 9--10). Compounds **4a** and **5i** were characterized by X-ray diffraction.[@cit11]

###### \[4+3\]-Annulations with various isoxazoles

  ![](c8sc00232k-u5.jpg){#ugr5}                                        
  ------------------------------- ---------------- -------- ----- ---- ----------------
  \(1\)                           H, H             **2b**   4     84   **4a** (X-ray)
  8                               **7a′**                              
  \(2\)                           H, Me            **2d**   3     75   **4b**
  \(3\)                           Me, H            **2c**   3     87   **4c**
  \(4\)                           Et, Et           **2e**   6     85   **4d**
  \(5\)                           *n*-Bu, *n*-Bu   **2f**   7     81   **4e**
  \(6\)                           Me, *n*-Bu       **2g**   3     82   **4f**
  \(7\)                           *n*-Bu, *c*-Pr   **2h**   2     77   **4g**
  \(8\)                           Ph, *n*-Bu       **2i**   4     69   **4h**
  \(9\)                           Ph, Ph           **2j**   6.5   61   **4i**
  30                              **5i** (X-ray)                       
  \(10\)                          Me, Ph           **2k**   4     71   **4j**
  ![](c8sc00232k-u6.jpg){#ugr6}   15               **5j**              

^*a*^\[**1b**\] = 0.15 M.

^*b*^Product yields are reported after separation from a silica column.

Our convenient synthesis of 4*H*-azepines provides new synthetic utilities; several new functionalizations are depicted in [Scheme 2](#sch2){ref-type="fig"}. NaBH~4~-reduction of species **3b** delivered an alcohol derivative **7a** in 84% yield. Selective hydrogenation of the same species afforded 2-aza-1,3-dien-5-one **7b** in 71% yield. A final treatment of 4*H*-azepine **3b** with NBS in acetone afforded compound **7c**, of which the molecular structure was determined by ^1^H NOE spectra.

![New functionalization of 4*H*-azepines.](c8sc00232k-s2){#sch2}

The Lewis-catalyzed rearrangement of 4*H*-azepines **3--4** to substituted pyridines **5** \[eqn (3)\] is unprecedented in 4*H*-azepine chemistry.[@cit10] We undertook such novel \[4+2\]-annulations between 3-en-1-ynamides **1** and isoxazoles **2** using Au([i]{.smallcaps})/Zn([ii]{.smallcaps}) in a relay series, as depicted in [Table 4](#tab4){ref-type="table"}. In the reactions of various 3-substituted 3-en-1-ynamides **1** (R^1^ = methyl, *n*-butyl, cyclopropyl and isopropyl) with 3,5-dimethylisoxazole **2a**, substituted pyridines **5a--5d** were obtained in satisfactory yields (51--73%, entries 1--4). In entry 1, if the reaction was performed with combined Au([i]{.smallcaps})/Zn([ii]{.smallcaps}) catalysts in a non-relay operation, compounds **5a** and **3b** were isolated in 35% and 28% yields respectively. For 3-en-1-ynamide **1a** bearing a NMs(*n*-butyl), the corresponding product **5e** was obtained in 63% yield (entry 5). We tested the reactions on 3,5-disubstituted isoxazoles **2e--2f** & **2h** bearing all alkyl substituents, producing desired **5f--5h** in good yields (69--78%, entries 6--8). For such disubstituted isoxazoles bearing R^4^ = Ph, the reactions afforded the desired pyridine derivatives **5i** and **5j** in 75--80% yields (entries 9--10). The molecular structures of compounds **5a** and **5i** were characterized by X-ray diffraction.[@cit11]

###### \[4+2\]-Annulations between 3-en-1-ynamides and isoxazoles

  ![](c8sc00232k-u7.jpg){#ugr7}                                                                                                            
  ------------------------------- ---------------- -------- ---------------- -------- ---- ----------------------------------------------- ----------------
  \(1\)                           Me, Me, Ts       **1b**   Me, Me           **2a**   19   73 (35)[^*c*^](#tab4fnc){ref-type="table-fn"}   **5a** (X-ray)
  \(2\)                           *n*-Bu, Me, Ts   **1k**   Me, Me           **2a**   33   64                                              **5b**
  \(3\)                           *c*-Pr, Me, Ts   **1h**   Me, Me           **2a**   20   56                                              **5c**
  \(4\)                           *i*-Pr, Me, Ts   **1g**   Me, Me           **2a**   15   51                                              **5d**
  \(5\)                           Me, *n*-Bu, Ms   **1a**   Me, Me           **2a**   28   63                                              **5e**
  \(6\)                           Me, Me, Ts       **1b**   *n*-Bu, *n*-Bu   **2f**   19   78                                              **5f**
  \(7\)                           Me, Me, Ts       **1b**   Et, Et           **2e**   16   69                                              **5g**
  \(8\)                           Me, Me, Ts       **1b**   *n*Bu, *c*-Pr    **2h**   20   75                                              **5h**
  \(9\)                           Me, Me, Ts       **1b**   Ph, Ph           **2j**   24   80                                              **5i** (X-ray)
  \(10\)                          Me, Me, Ts       **1b**   Me, Ph           **2k**   30   75                                              **5j**

^*a*^\[**1**\] = 0.15 M.

^*b*^Product yields are reported after separation from a silica column.

^*c*^The value in parentheses is reported using a mixture of IPrAuCl/AgNTf~2~ (10 mol%) and Zn(OTf)~2~ (20 mol%) in hot DCE (70 °C, 48 h); **3b** was also isolated in 28% yield.

[Scheme 3](#sch3){ref-type="fig"} rationalizes the crucial roles of substituents of 3-en-1-ynamides in the chemoselectivity that relies on two conformational structures **D***versus***D′**. The N-attack of isoxazole at gold-π-ynamide **A** is expected to form a gold-carbene **D′**, which can be visualized as a gold-stabilized cycloheptatrienyl cation. Conformation **D** is favorable with R = H, which prefers aza-Nazarov reactions.[@cit12] When a C(3)-substituent is present (R = alkyl and aryl), all σ-*cis* configured species **D′** are the preferable geometry to induce novel 6π electrocyclizations. This ring closure is expected to proceed through an attack of enamide at the alkenylgold moiety that is also visualized as a gold-stabilized cation. Additional C(4)-substituents render the formation of cations **D′** difficult, thus yielding pyrrole **6** as byproducts. A loss of an acidic proton from seven-membered cations **E** is expected to yield azepines **3--4**. 4*H*-Azepines **3--4** bear an enone conjugated with a triene; this extensive conjugation is very stable to impede a 6π electrocyclization of their triene moieties unless a Lewis acid is present. Zn(OTf)~2~ likely coordinates with the carbonyl of 4*H*-azepine **3** to generate a 2-azapentadienyl cation **F** bearing a zinc enolate, further enabling an intramolecular cyclization to generate species **G**. A 1,2-acyl shift[@cit14] of species **G** delivers the observed product **5**.[@cit13]

![A plausible reaction mechanism.](c8sc00232k-s3){#sch3}

Conclusions
===========

In summary, this work describes new gold-catalyzed \[4+3\] annulations[@cit15] of 3-substituted 3-en-1-ynamides with isoxazoles to form 4*H*-azepines. A relay catalysis is also developed with Au([i]{.smallcaps})/Zn([ii]{.smallcaps}) catalysts to achieve \[4+2\] annulations from the same reactants. The mechanisms of gold-catalyzed \[4+3\] annulations involve unprecedented 6π electrocyclizations of 3-azacycloheptatrienyl cations to form 4*H*-azepines **3--4** efficiently. Control experiments confirm that 4*H*-azepines **3--4** are catalyzed by Zn(OTf)~2~ to undergo new rearrangement reactions to form substituted pyridine derivatives.
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